Tianjin Medical University Cancer Institute & Hospital — Tianjin

Public research footprint of Tianjin Medical University Cancer Institute & Hospital, compiled from the ClinicalTrials.gov public registry.

327

Registered studies

214

Active

132

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Relapsed/Refractory Follicular Lymphoma · Neoplasm Metastasis · Endometrial Cancer · Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Recently updated registry entries

NCT07738679 — Clinical Trial Evaluating the Efficacy and Safety of TQB3454 Tablets in Participants With… (Not Yet Recruiting)
NCT07736001 — A Single-arm, Multi-center, Phase II Exploratory Clinical Study to Evaluate the Efficacy… (Not Yet Recruiting)
NCT07174336 — A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Tianjin Medical University Cancer Institute & Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.